A systematic review of qualitative research exploring patient and health professional perspectives of breakthrough cancer pain.
Breakthrough cancer pain
Health professional
Palliative care
Patients
Qualitative
Systematic review
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
09 Oct 2023
09 Oct 2023
Historique:
received:
28
03
2023
accepted:
25
09
2023
medline:
1
11
2023
pubmed:
9
10
2023
entrez:
9
10
2023
Statut:
epublish
Résumé
Breakthrough cancer pain (BtCP) is a prevalent health issue which is difficult to manage. A plethora of quantitative research in this area exists. There is a paucity of research on the perspectives of health professionals and patients surrounding domains impacting effective treatment, including definitions of BtCP, treatment, and education opportunities. This review aims to identify and synthesize the extent of qualitative research exploring health professional and patient perspectives of BtCP. A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) approach was undertaken. The approach was registered with Prospero. MEDLINE, EMBASE, and Web of Science were searched for peer-reviewed literature published any date prior to May 19, 2022. Eligible sources must have considered health professional and/or patient perspectives of BtCP. A narrative synthesis approach was utilized. Three sources met the review criteria. One source explored nurse perspectives, while two sources explored patient perspectives. Study quality was moderate to high. Overlapping themes across the three studies included communication, defining BtCP, impact of BtCP, management of BtCP, perceptions of BtCP, analgesia and pain relief, and training and professional development. Given limited research investigating clinician and patient perspectives of BtCP, a rich understanding informed by exploratory qualitative methods around identification, best management strategies, professional development, and factors promoting and inhibiting best practice remains unclear. Further qualitative inquiry is warranted, and it is expected such research will inform BtCP clinical guidelines.
Identifiants
pubmed: 37812248
doi: 10.1007/s00520-023-08076-9
pii: 10.1007/s00520-023-08076-9
pmc: PMC10562491
doi:
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
619Informations de copyright
© 2023. Crown.
Références
Brant JM et al (2017) Breakthrough cancer pain: a systematic review of pharmacologic management. CJON 21(3):71–80
doi: 10.1188/17.CJON.S3.71-80
Mercadante S, Portenoy RK (2016) Breakthrough cancer pain: twenty-five years of study. Pain 157(12):2657–2663
doi: 10.1097/j.pain.0000000000000721
pubmed: 27653423
Davies AN (2006) Cancer-related breakthrough pain. Br J Hosp Med (Lond) 67(8):414–416
doi: 10.12968/hmed.2006.67.8.21960
pubmed: 16918095
Fortner BV, Okon TA, Portenoy RK (2002) A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 3(1):38–44
doi: 10.1054/jpai.2002.27136
pubmed: 14622852
Simmonds MA (1999) Management of breakthrough pain due to cancer. Oncology (Williston Park) 13(8):1103–8 (discussion 1110, 1113-4)
pubmed: 10499244
Canal-Sotelo J et al (2018) Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm. BMC Palliat Care 17(1):81
doi: 10.1186/s12904-018-0336-y
pubmed: 29807537
pmcid: 5971419
Deandrea S et al (2014) Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage 47(1):57–76
doi: 10.1016/j.jpainsymman.2013.02.015
pubmed: 23796584
Vellucci R et al (2016) What to do, and what not to do, when diagnosing and treating breakthrough cancer pain (BTcP): expert opinion. Drugs 76(3):315–330
doi: 10.1007/s40265-015-0519-2
pubmed: 26755179
pmcid: 4757619
World Health Organization (2018) WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents
Zeppetella G et al (2014) A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes. J Pain Symptom Manage 47(4):772-785.e5
doi: 10.1016/j.jpainsymman.2013.05.020
pubmed: 23981487
Vellucci R, Mediati R, Gasperoni S, Mammucari M, Marinangeli F, Romualdi P (2017) Assessment and treatment of breakthrough cancer pain: from theory to clinical practice. J Pain Res 10:2147–2155
doi: 10.2147/JPR.S135807
pubmed: 29066928
pmcid: 5604430
Rudowska J (2012) Management of breakthrough pain due to cancer. Contemp Oncol (Pozn) 16(6):498–501
pubmed: 23788935
Davies AN et al (2009) The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 13(4):331–338
doi: 10.1016/j.ejpain.2008.06.014
pubmed: 18707904
Mercadante S (2018) Non pharmacological interventions and non-fentanyl pharmacological treatments for breakthrough cancer pain: a systematic and critical review. Crit Rev Oncol Hematol 122:60–63
doi: 10.1016/j.critrevonc.2017.12.016
pubmed: 29458790
Davies AN et al (2018) Breakthrough cancer pain (BTcP) management: a review of international and national guidelines. BMJ Support Palliat Care 8(3):241–249
doi: 10.1136/bmjspcare-2017-001467
pubmed: 29875184
Camps Herrero C et al (2020) Breakthrough cancer pain: review and calls to action to improve its management. Clin Transl Oncol 22(8):1216–1226
doi: 10.1007/s12094-019-02268-8
pubmed: 32002739
Suresh NV et al (2022) Clinical Practice Guidelines in the management of breakthrough cancer pain: a systematic review using the Appraisal of Guidelines for Research and Evaluation (AGREE II) Instrument. Pain Manag Nurs 23(4):411–417
doi: 10.1016/j.pmn.2022.02.010
pubmed: 35305935
Askarzai W, Unhelkar B (2017) Research methodologies: an extensive overview. Int J Sci Res Methodol 6(4):21–42
Zeppetella G (2009) Impact and management of breakthrough pain in cancer. Curr Opin Support Palliat Care 3(1):1–6
doi: 10.1097/SPC.0b013e3283260658
pubmed: 19365156
Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097
doi: 10.1371/journal.pmed.1000097
pubmed: 19621072
pmcid: 2707599
Lippiett KA et al (2019) Patients and informal caregivers’ experiences of burden of treatment in lung cancer and chronic obstructive pulmonary disease (COPD): a systematic review and synthesis of qualitative research. BMJ Open 9(2):e020515
doi: 10.1136/bmjopen-2017-020515
pubmed: 30813114
pmcid: 6377510
Popay J et al (2006) Guidance on the conduct of narrative synthesis in systematic reviews. Accessed https://www.lancaster.ac.uk/media/lancaster-university/content-assets/documents/fhm/dhr/chir/NSsynthesisguidanceVersion1-April2006.pdf
Critical Appraisal Skills Programme (2018) CASP Checklist Accessed casp-uk.net
Long HA, French DP, Brooks JM (2020) Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis. Res Methods Med Health Sci 1(1):31–42
Soden K et al (2010) How do nurses assess and manage breakthrough pain in specialist palliative care inpatient units? A multicentre study. Palliat Med 24(3):294–298
doi: 10.1177/0269216309355918
pubmed: 20015919
Liu Q et al (2018) Breakthrough pain: a qualitative study of patients with advanced cancer in northwest China. Pain Manag Nursing 19(5):506–515
doi: 10.1016/j.pmn.2017.11.006
Webber K, Davies AN, Cowie MR (2011) Breakthrough pain: a qualitative study involving patients with advanced cancer. Supp Care Cancer 19(12):2041–2046
doi: 10.1007/s00520-010-1062-z
Lopez RL et al (2018) Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study. Clin Transl Oncol 20(5):613–618
doi: 10.1007/s12094-017-1756-5
Mercadante S et al (2013) Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients. Curr Med Res Opin 29(1):93–97
doi: 10.1185/03007995.2012.755120
pubmed: 23198976
Soden K et al (2013) How do nurses in specialist palliative care assess and manage breakthrough cancer pain? A multicentre study. Int J Palliat Nurs 19(11):528–534
doi: 10.12968/ijpn.2013.19.11.528
pubmed: 24263896
Mercadante S, Villari P, Casuccio A (2011) An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Supp Care Cancer 19(7):979–983
doi: 10.1007/s00520-010-0919-5
Webber K, Davies AN, Cowie MR (2010) Communication issues in patients with breakthrough cancer pain. Palliat Med 24(4 Suppl. 1):S211
Mercadante S et al (2021) The prevalence and characteristics of breakthrough cancer pain in patients receiving low doses of opioids for background pain. Cancers (Basel) 13(5)
Renjith V et al (2021) Qualitative methods in health care research. Int J Prev Med 12:20
pubmed: 34084317
pmcid: 8106287
Hamano J, Hanari K, Tamiya N (2020) End-of-life care preferences of the general public and recommendations of healthcare providers: a nationwide survey in Japan. BMC Palliat Care 19(1):38
doi: 10.1186/s12904-020-00546-9
pubmed: 32209096
pmcid: 7093951
Scholz B et al (2019) Consumer and carer leadership in palliative care academia and practice: a systematic review with narrative synthesis. Palliat Med 33(8):959–968
doi: 10.1177/0269216319854012
pubmed: 31199194
Hasson F et al (2020) International palliative care research priorities: a systematic review. BMC Palliat Care 19(1):16
doi: 10.1186/s12904-020-0520-8
pubmed: 32013949
pmcid: 6998205